Omnicell (MEX:OMCL) Cyclically Adjusted PS Ratio: (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OMCL Omnicell Inc MEX:OMCL
75 GF Score
Price MXN761.16
GF Value MXN796.23
! 6 Warning Signs
View Full Analysis

What is Omnicell Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Omnicell  (MEX:OMCL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Omnicell Cyclically Adjusted PS Ratio Related Terms


Omnicell Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Omnicell's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell Cyclically Adjusted PS Ratio Chart

Omnicell Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.67 2.34 1.61 1.79 1.72

Omnicell Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.14 1.16 1.72 1.25 0.00

MEX:OMCL vs HTFL, TDOC, OMDA: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, Omnicell's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Omnicell's Cyclically Adjusted PS Ratio falls into.


MEX:OMCL
75GF Score
Omnicell Inc MEX:OMCL
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omnicell Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Omnicell's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Omnicell's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=117.656/333.9520*333.9520
=117.656

Current CPI (Jun. 2026) = 333.9520.

Omnicell Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 92.163 241.428 127.483
201612 96.688 241.432 133.740
201703 75.926 243.801 104.001
201706 85.288 244.955 116.275
201709 86.960 246.819 117.659
201712 89.585 246.524 121.356
201803 83.589 249.554 111.858
201806 92.683 251.989 122.829
201809 93.510 252.439 123.705
201812 100.125 251.233 133.091
201903 92.912 254.202 122.061
201906 97.247 256.143 126.788
201909 104.921 256.759 136.465
201912 107.938 256.974 140.271
202003 123.465 258.115 159.740
202006 108.012 257.797 139.919
202009 108.050 260.280 138.633
202012 112.613 260.474 144.380
202103 111.026 264.877 139.980
202106 115.254 271.696 141.663
202109 126.076 274.310 153.488
202112 127.136 278.802 152.285
202203 132.480 287.504 153.883
202206 144.116 296.311 162.423
202209 152.801 296.808 171.923
202212 129.889 296.797 146.149
202303 116.706 301.836 129.124
202306 112.719 305.109 123.375
202309 114.100 307.789 123.799
202312 96.572 306.746 105.137
202403 89.329 312.332 95.512
202406 110.148 314.175 117.082
202409 119.778 315.301 126.863
202412 135.657 315.605 143.543
202503 118.399 319.799 123.639
202506 116.440 322.561 120.552
202509 124.145 324.800 127.643
202512 124.316 324.054 128.113
202603 121.628 330.213 123.005
202606 117.656 333.952 117.656

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Omnicell (MEX:OMCL) Overvalued in 2026?

Based on GuruFocus' analysis, Omnicell stock appears to be undervalued. The current stock price of MXN761.16 is trading 4.4% below its estimated GF Value™ of MXN796.23.

Key valuation signals for MEX:OMCL:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: MXN796.23 vs. price of MXN761.16 (4.4% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the MEX:OMCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omnicell Business Description

Other Exchanges OMCL:USAOC9:Germany
Address 4220 North Freeway, Fort Worth, TX, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
75GF Score

Get the complete analysis for MEX:OMCL

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN761.16
Price
MXN796.23
GF Value